1. Understanding the Signaling Pathways Related to the Mechanism and Treatment of Diabetic Peripheral Neuropathy
- Author
-
Guo-Ming Shen, Fan-jing Wang, Jun-long Ma, He-Yong Tang, and Ai-juan Jiang
- Subjects
medicine.medical_specialty ,Glycosylation ,medicine.medical_treatment ,Bioinformatics ,Endocrinology ,Diabetic Neuropathies ,Internal medicine ,Diabetes mellitus ,medicine ,Animals ,Humans ,Nerve Growth Factors ,Foot ulcers ,Protein Kinase C ,Dyslipidemias ,Mechanism (biology) ,business.industry ,Metabolic disorder ,Peripheral Nervous System Diseases ,Pain management ,medicine.disease ,Oxidative Stress ,Peripheral neuropathy ,Amputation ,Signal transduction ,business ,Signal Transduction - Abstract
Worldwide, the most prevalent metabolic disorder is diabetes mellitus (DM), an important condition that has been widely studied. Diabetic peripheral neuropathy (DPN), a complication that can occur with DM, is associated with pain and can result in foot ulcers and even amputation. DPN treatments are limited and mainly focus on pain management. There is a clear need to develop treatments for DPN at all stages. To make this progress, it is necessary to understand the molecular signaling pathways related to DPN. For this review, we aimed to concentrate on the main signaling cascades that contribute to DPN. In addition, we provide information with regard to treatments that are being explored.
- Published
- 2019
- Full Text
- View/download PDF